↓ Skip to main content

Cochrane Database of Systematic Reviews

Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma

Overview of attention for article published in Cochrane database of systematic reviews, August 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
126 Mendeley
Title
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
Published in
Cochrane database of systematic reviews, August 2012
DOI 10.1002/14651858.cd003915.pub4
Pubmed ID
Authors

Claire L Vale, Jayne Tierney, Sarah J Bull, Paul R Symonds

Abstract

Although endometrial adenocarcinoma is a common gynaecological cancer, a comparatively small proportion of patients present with, or develop, recurrent or advanced disease. However, for those women whose disease does progress or recur the prognosis is poor and the best treatment is yet to be identified. Co-morbidity, including obesity and cardiac disease, and concerns over toxicity have prevented more extensive studies of cytotoxic chemotherapy, although there are a number of active agents.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 124 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 21%
Researcher 21 17%
Student > Bachelor 12 10%
Other 11 9%
Student > Postgraduate 8 6%
Other 23 18%
Unknown 24 19%
Readers by discipline Count As %
Medicine and Dentistry 57 45%
Nursing and Health Professions 12 10%
Biochemistry, Genetics and Molecular Biology 9 7%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Agricultural and Biological Sciences 4 3%
Other 12 10%
Unknown 27 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2020.
All research outputs
#4,918,883
of 18,129,145 outputs
Outputs from Cochrane database of systematic reviews
#7,208
of 11,812 outputs
Outputs of similar age
#35,748
of 140,594 outputs
Outputs of similar age from Cochrane database of systematic reviews
#57
of 109 outputs
Altmetric has tracked 18,129,145 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 11,812 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.5. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 140,594 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.